Evidence for a central cholinergic deficit in congenital ornithine transcarbamylase deficiency

Developmental Neuroscience

Volumn 20, Issue 4-5, 1998, Pages 478-484

  Butterworth, R F ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Acetylcholine; Ammonia; Congenital hyperammonemia; Mental retardation; Muscarinic receptors; Ornithine transcarbamylase deficiency

Indexed keywords

2 OXOGLUTARIC ACID; ACETYL COENZYME A; BENZOIC ACID; CHOLINE ACETYLTRANSFERASE; LEVACECARNINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ORNITHINE CARBAMOYLTRANSFERASE; PHENYLACETIC ACID DERIVATIVE; PYRUVIC ACID;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ASTROCYTOSIS; BINDING SITE; BRAIN ATROPHY; BRAIN VENTRICLE DILATATION; CELL LOSS; CEREBRAL PALSY; CHOLINERGIC ACTIVITY; COGNITIVE DEFECT; CONFERENCE PAPER; ENZYME DEFICIENCY; ENZYME SYNTHESIS; LIVER TRANSPLANTATION; MENTAL DEFICIENCY; MOUSE; MYELINATION; NEUROPATHOLOGY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SEIZURE; UREA CYCLE;

ANIMALS; BRAIN; CHOLINE DEFICIENCY; CHOLINE O-ACETYLTRANSFERASE; DISEASE MODELS, ANIMAL; MICE; MICE, MUTANT STRAINS; ORNITHINE CARBAMOYLTRANSFERASE;

EID: 0031762572     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017346     Document Type: Conference Paper

References (53)

1. Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED: Neurologic outcome in children with inborn errors of urea synthesis. N Engl J Med 1984;310:1500-1505.
2. Harding BN, Leonard JV, Erdohazi M: Ornithine transcarbamylase deficiency: Neuropathological study. Eur J Pediatr 1984;141:215-220.
3. Dolman CL, Clasen RA, Dorovini-Zis K: Severe cerebral damage in ornithine transcarbamylase deficiency. Clin Neuropathol 1988;7: 10-15.
4. Harper CG, Butterworth RF: Nutritional and metabolic disorders, in Graham DI, Lantos PL (eds): Greenfield's Neuropathology. London, Arnold, 1997, pp 601-655.
5. Gregorios JB, Mozes LW, Norenberg LOB, Norenberg MD: Morphologic effects of ammonia on primary astrocyte cultures. I. Light microscopic studies. J Neuropathol Exp Neurol 1985;44:397-403.
6. Kendall BE, Kingsley DPE, Leonard JV, Lingam S, Oberholzer VG: Neurological features and computed tomography of the brain in children with ornithine carbamoyl transferase deficiency. J Neurol Neurosurg Psychiatry 1983; 46:28-34.
7. Takayanagi M, Ohtake A, Ogura N, Nakajima H, Hoshino M: A female case of ornithine transcarbamylase deficiency with marked computed tomographic abnormalities of the brain. Brain Dev 1984;6:58.
8. Filloux F, Townsend JJ, Leonard C: Ornithine transcarbamylase deficiency: Neuropathologic changes acquired in utero. J Pediatr 1986;108: 942-945.
9. Qureshi IA: Animal models of hereditary hyperammonemias, in Boulton A, Baker G, Butterworth R (eds): Neuromethods Volume 22: Animal Models of Neurological Disease, II. Clifton, N.J., Humana Press, 1992, pp 329-356.
10. Veres G, Gibbs RA, Scherer SE, Caskey CT: The molecular basis of the sparse fur mutation. Science 1987;237:415-417.
11. Ratnakumari L, Qureshi IA, Butterworth RF: Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice. Biochem Biophys Res Commun 1992;184:745-751.
12. Batshaw ML, Hyman SL, Coyle JT, Robinson MB, Qureshi IA, Millits ED, Quaskey S: Effect of sodium benzoate and sodium phenylacetate on brain 5-HT turnover in the ornithine transcarbamylase-deficient sparse-fur mouse. Pediatr Res 1988;23:368-374.
13. Connelly A, Cross JH, Gadian DG. Hunter V, Kirkham FJ, Leonard JV: Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency. Pediatr Res 1993;33:77-81.
14. Raghavendra Rao VL, Qureshi IA, Butterworth RF: Activities of monoamine oxidase-A and -B are altered in the brains of congenitally hyperammonemic sparse-fur (spf) mice. Neurosci Lett 1994;170:27-30.
15. 3H]-PK 11195 in congenital ornithine transcarbamylase deficient sparse-fur mouse. Pediatr Res 1993;34:777-780.
16. Anholt RRH: Mitochondrial benzodiazepine receptors as potential modulators of intermediary metabolism. Trends Pharmacol Sci 1986; 7:506-511.
17. Shiraishi T, Black KL, Ikesaki K: Peripheral benzodiazepine receptor ligands induce morphological changes in mitochondria of cultured glioma cells. Soc Neurosci Abstr 1990;16:214-216.
18. A receptor by steroids. Semin Neurosci 1991;3: 231-239.
19. 3H-PK 11195 in rat brain following portacaval anastomosis. Brain Res 1992;585:295-298.
20. Desjardins P, Bandeira P, Raghavendra Rao VL, Ledoux S, Butterworth RF: Increased expression of the peripheral-type benzodiazepine receptor-isoquinoline carboxamide binding protein in mRNA in brain following portacaval anastomosis. Brain Res 1997;758:255-258.
21. 3H]PK11195. Neurosci Lett 1994;177: 35-38.
22. Bachmann C, Colombo JP: Increase of tryptophan and 5-hydroxyindoleacetic acid in the brain of ornithine carbamoyl transferase deficient sparse-fur mice. Pediatr Res 1984;18: 372-375.
23. 1a receptors are altered in the congenitally hyperammonemic sparse fur mouse. J Neurochem 1992;58:1016-1022.
24. 3H]MK801 binding sites in brain in congenital ornithine transcarbamylase deficiency. Metab Brain Dis 1995;10:249-255.
25. Ratnakumari L, Butterworth RF, Marescau B, Qureshi IA: Arginine-related guanidino compounds and nitric oxide synthase in the brain of ornithine transcarbamylase deficient spf mutant mouse: effect of metabolic arginine deficiency, in Dedeyn PP, Marescau B, Qureshi IA, Mori A (eds): Guanidino Compounds. John Libby, 1996, pp 17-20.
26. Ratnakumari L, Qureshi IA, Maysinger D, Butterworth RF: Developmental deficiency of the cholinergic system in congenitally hyperammonemic spf mice: effect of acetyl-L-carnitine. J Pharmacol Exp Ther 1995;274:437-443.
27. Ratnakumari L, Qureshi IA, Butterworth RF: Regional amino acid neurotransmitter changes in brains of spf/Y mice with congenital ornithine transcarbamylase deficiency. Metab Brain Dis 1994;9:43-52.
28. 2 receptor changes in congenital ornithine transcarbamylase deficiency. Pediatr Res 1996;40: 25-28.
29. Arauja DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion S: Differential alterations of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J Neurochem 1988;50:1914-1923.
30. Michalak A, Butterworth RF: Ornithine transcarbamylase deficiency: pathophysiologic mechanisms and new prospects for therapy. Metab Brain Dis 1997;12:163-174.
31. McKhann GM, Tower DB: Ammonia toxicity and cerebral oxidative metabolism. Am J Physiol 1961;200:420-424.
32. Cooper AJL, Lai JCK: Cerebral ammonia metabolism in normal and hyperammonemic rats. Neurochem Pathol 1987;6:67-95.
33. Erecinska M, Pastuszko A, Wilson DF, Nelson D: Ammonia-induced release of neurotransmitters from rat brain synaptosomes: differences between the effects on amines and amino acids. J Neurochem 1987;49:1258-1265.
34. 3H]arginine uptake in brain following portacaval anastomosis. J Neurochem 1995; 65:677-681.
35. Raghavendra Rao VL, Audet RM, Butterworth RF: Cerebral nitric oxide synthase activities in experimental hepatic encephalopathy, in Dedeyn PP, Marescau B, Qureshi IA, Mori A (eds): Guanidino Compounds. John Libby, 1996, pp 21-26.
36. Raghavendra Rao VL, Audet RM, Butterworth RF: Increased neuronal nitric oxide synthase expression in brain following portacaval anastomosis. Brain Res 1997;765:169-172.
37. Bender AS, Norenberg MD: Effect of ammonia on L-glutamate uptake in cultured astrocytes. Neurochem Res 1996;21:567-573.
38. Knecht K, Michalak A, Rose C, Rothstein JD, Butterworth RF: Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure. Neurosci Lett 1997;229:201-203.
39. Gibson GE, Ksiezak-Reding H, Sheu KF, Mykytyn V, Blass JP: Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal. Neurochem Res 1984;9:803-814.
40. Calingasan NY, Baker H, Sheu KF, Gibson GE: Distribution of the alpha-ketoglutarate dehydrogenase complex in rat brain. J Comp Neurol 1994;346:461-469.
41. Robinson MB, Heyes MP, Anegawa NJ, Gorry E, Djali S, Mellits ED, Batshaw ML: Quinolinate in brain and cerebrospinal fluid in rat models of congenital hyperammonemia. Pediatr Res 1992;32:483-488.
42. Batshaw ML, Robinson MB, Hyland K, Djali S, Heyes MP: Quinolinic acid in children with congenital hyperammonemia. Ann Neurol 1993;34:676-681.
43. Robinson MB, Hopkins K, Batshaw ML, McLaughlin BA, Heyes MP, Oster-Granite ML: Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse. Dev Brain Res 1995;90:35-44.
44. Bakker MHM, Foster AC: An investigation of the mechanisms of delayed neuron degeneration caused by direct injection of quinolinic acid into the rat striatum in vivo. Neuroscience 1991;42:387-395.
45. James JH, Escourrou J, Fischer JE: Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis. Science 1978;200:1395-1397.
46. Schwarcz R, Whetsell WO Jr, Mangano RM: Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 1983;219:316-318.
47. Minana MD, Marcaida G, Grisolia S, Felipo V: Prenatal exposure of rats to ammonia impairs NMDA receptor function and affords delayed protection against ammonia toxicity and glutamate neurotoxicity. J Neuropathol Exp Neurol 1995;54:644-650.
48. Brusilow SW, Horwich AL: Urea cycle enzymes, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Basis of Inherited Disease, 7th edition. New York, McGraw-Hill Information Services, 1995, pp 1187-1232.
49. Todo S, Starzl TE, Tzakis A, Benkov KJ, Kalousek F, Saheki T, Tanikawa K, Fenton WA. Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 1992;15:419-422.
50. Hasegawa T, Tzakis AG, Todo S, Reyes J, Nour B, Finegold DN, Starzl TE: Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy. J Pediatr Surg 1995;30:863-865.
51. Ye X, Robinson MB, Batshaw ML, Furth EE, Smith I, Wilson JM: Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors. J Biol Chem 1996;271:3639-3646.
52. Tucek S: Regulation of acetylcholine synthesis in the brain. J Neurochem 1985;44:11-24.
53. Bassi S, Ferrarese C, Finola MG, Frattola L, Iannucelli M, Meregalli S, Piotti R: L-acetyl-carnitine in Alzheimer Disease (AD) and senile dementia of the Alzheimer type (SDAT), in Agnoli A, Cahn J, Larsen N, Mayeux, R (eds): Senile Dementias (Second International Symposium). Paris, John Libbey Eurotext, 1988, pp 461-466.